all report title image

OPIOID DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Opioid Drugs Market , By Drug Class (Alkaloids (Morphine, codeine), Semisynthetic Opioids (Oxycodone, Hydrocodone, Hydromorphone), Synthetic Opioids (Fentanyl, Alfentanil)), By Application (Analgesia, Cough Suppression, Diarrhea Suppression, Others), By Route of Administration (Oral, Topical, Parenteral, Others (Intramuscular, etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In: 01 Apr, 2026
  • Code: CMI1017
  • Page number: 151
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Class
      • Market Snippet, By Application
      • Market Snippet, By Route of Administration
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Recent Product Launches
    • Epidemiology
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • Reimbursement Scenario
    • PEST Analysis
    • PORTER’S Analysis
  4. Global Opioid Drugs Market, By Drug Class, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Alkaloids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Segment Trends
        • Morphine
        • codeine
    • Semisynthetic Opioids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Segment Trends
        • Oxycodone
        • Hydrocodone
        • Hydromorphone
    • Synthetic Opioids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Segment Trends
        • Fentanyl
        • Alfentanil
  5. Global Opioid Drugs Market, By Application, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Analgesia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Segment Trends
    • Cough Suppression
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Segment Trends
    • Diarrhea Suppression
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Segment Trends
  6. Global Opioid Drugs Market, By Route of Administration, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Segment Trends
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Segment Trends
    • Parenteral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Segment Trends
    • Others (Intramuscular, etc.)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Segment Trends
  7. Global Opioid Drugs Market, By Distribution Channel, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  8. Global Opioid Drugs Market, By Region, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (USD Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (USD Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (USD Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (USD Bn)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape

    • Company Profiles
      • Teva Pharmaceutical Industries Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Johnson & Johnson
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Endo International plc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Lupin Limited
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Cadila Healthcare Limited
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Purdue Pharma L.P.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • AbbVie Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Fresenius Kabi
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Mallinckrodt Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Pfizer Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Rhodes Pharmaceuticals L.P.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Sun Pharmaceutical Industries Limited
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Nesher Pharmaceuticals (USA) LLC
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Amneal Pharmaceuticals LLC
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Trevena Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Aurobindo Pharma Limited
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
  10. Section

    • References
    • Research Methodology
    • About us and Sales Contact
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.